Open Access. Powered by Scholars. Published by Universities.®

Biochemistry, Biophysics, and Structural Biology Commons

Open Access. Powered by Scholars. Published by Universities.®

None

Orthopedics

2005

Articles 1 - 2 of 2

Full-Text Articles in Biochemistry, Biophysics, and Structural Biology

Nitrosamine 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone-Induced Pulmonary Adenocarcinomas In Syrian Golden Hamsters Contain Beta 2-Adrenergic Receptor Single-Nucleotide Polymorphisms, T Masi, Maria Cekanova, K Walker, H Bernart, M Majidi, Jm Becker, Hildegard Schuller Sep 2005

Nitrosamine 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone-Induced Pulmonary Adenocarcinomas In Syrian Golden Hamsters Contain Beta 2-Adrenergic Receptor Single-Nucleotide Polymorphisms, T Masi, Maria Cekanova, K Walker, H Bernart, M Majidi, Jm Becker, Hildegard Schuller

Maria Cekanova MS, RNDr, PhD

Cigarette smoking contributes to the development of lung cancer throughout the world, with cases of pulmonary adenocarcinoma (PAC) the most numerous. Nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), which is formed from nicotine, has been demonstrated to cause mutations in genes that affect cell regulation and proliferation. Moreover, NNK has been shown to interact directly with and stimulate beta adrenergic receptor (ADRB) signal transduction pathways. Our goal was to determine whether single-nucleotide polymorphisms (SNPs) in the Adrb2 from PAC tumors were induced in golden hamsters by the injection of NNK. Here we report the cloning and sequencing of Adrb2 clones ...


Nnk-Induced Hamster Lung Adenocarcinomas Over-Express Beta2-Adrenergic And Egfr Signaling Pathways, Hildegard Schuller, Maria Cekanova Jun 2005

Nnk-Induced Hamster Lung Adenocarcinomas Over-Express Beta2-Adrenergic And Egfr Signaling Pathways, Hildegard Schuller, Maria Cekanova

Maria Cekanova MS, RNDr, PhD

Pulmonary adenocarcinoma (PAC) is the most common type of human lung cancer. A diagnosis of PAC, history of non-smoking and presence of mutations in the EGFR are predictive factors for responsiveness of lung cancer to EGFR-specific tyrosine kinase inhibitors. Unfortunately, less than 50% of PAC cases demonstrate this mutation-based responsiveness. Our immunohistochemical analysis of NNK-induced PAC in hamsters demonstrates the simultaneous over-expression of a beta2-adrenergic receptor pathway, including PKA, cAMP, CREB and phosphorylated CREB and of an EGFR pathway, including over-expression of EGFR-specific phosphorylated tyrosine kinase, Raf-1 and ERK1/2 and their phosphorylated forms. These findings implicate, for the first ...